Publications by authors named "Petros Grivas"

100Publications

The Effectiveness of Shared Compared to Informed Decision Making for Prostate Cancer Screening in a High-Risk African American Population: A Randomized Control Trial.

Cancer Invest 2021 Jan 7:1-9. Epub 2021 Jan 7.

Department of Hematology and Medical Oncology, South Pointe Hospital, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article and Find Full Text PDF
January 2021

Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015.

Urology 2020 Dec 26. Epub 2020 Dec 26.

Department of Urology, University of Washington Medical Center, WA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, WA; Department of Urology, Seattle Veterans Affair, WA.

View Article and Find Full Text PDF
December 2020

Alterations of DNA damage response genes correlate with response and overall survival in anti-PD-1/PD-L1-treated advanced urothelial cancer.

Cancer Med 2020 Dec 23;9(24):9365-9372. Epub 2020 Oct 23.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA.

View Article and Find Full Text PDF
December 2020

Cancer and COVID-19 - Authors' reply.

Lancet 2020 10;396(10257):1067-1068

Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address:

View Article and Find Full Text PDF
October 2020

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.

N Engl J Med 2020 09 18;383(13):1218-1230. Epub 2020 Sep 18.

From Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St. Bartholomew's Hospital, London (T.P.); Sungkyunkwan University Samsung Medical Center, Seoul, South Korea (S.H.P.); Centre Jean Bernard Clinique Victor Hugo, Le Mans (E.V.), and Gustave Roussy, INSERM Unité 981, Université Paris-Saclay, Villejuif (Y.L.) - both in France; the Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni (C.C.), and Pfizer, Milan (C.F., A.P.) - both in Italy; the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Clinical Medicine, Macquarie University, Sydney (H.G.); the Division of Oncology, Department of Medicine, University General Hospital of Patras, Patras, Greece (H.K.); the Institute for Oncology and Radiology of Serbia, Belgrade (S.R.); the Department of Medical Oncology, Algemeen Ziekenhuis Klina, Brasschaat, Belgium (W.D.); Patient Area Pelvic Cancer, Theme Cancer, Karolinska University Hospital, and the Department of Oncology-Pathology, Karolinska Institute, Solna, Sweden (A.U.); Princess Margaret Cancer Centre, University Health Network, Toronto (S.S.S.); the Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan (N.T.); the State Institution of Healthcare Regional Clinical Oncology Dispensary, Omsk, Russia (E.K.); the Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York (C.N.S.); the Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston (J.B.), and Pfizer, Cambridge (R.L., J.W.) - both in Massachusetts; Inova Schar Cancer Institute, Fairfax, VA (J.B.A.-C.); Yale Cancer Center, New Haven (D.P.P.), and Pfizer, Groton (B.H.) - both in Connecticut; Pfizer, La Jolla, CA (C.D., J.A.B.-H.); Pfizer, Porto Salvo, Portugal (N.C.); and the Department of Medicine, Division of Oncology, University of Washington, and the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle (P.G.).

View Article and Find Full Text PDF
September 2020

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities.

Cancer Treat Res Commun 2020 16;25:100179. Epub 2020 May 16.

Division of Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, United States. Electronic address:

View Article and Find Full Text PDF
May 2020

Comparison of Health Care Utilization at the End of Life Among Patients With Cancer in Alberta, Canada, Versus Washington State.

JCO Oncol Pract 2020 Dec 17;16(12):e1543-e1552. Epub 2020 Aug 17.

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA.

View Article and Find Full Text PDF
December 2020

Immunotherapy-Related Colitis: An Emerging Challenge and a Quest for Prospective Data.

JCO Oncol Pract 2020 Aug;16(8):464-465

University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article and Find Full Text PDF
August 2020

"Real-world" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma.

Urol Oncol 2021 Jan 8;39(1):76.e15-76.e22. Epub 2020 Aug 8.

University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article and Find Full Text PDF
January 2021

Immunotherapy-based combination strategies for advanced urothelial cancer: A long quest.

Cancer 2020 Oct 5;126(20):4446-4450. Epub 2020 Aug 5.

Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.

View Article and Find Full Text PDF
October 2020

Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.

Cell Mol Life Sci 2020 Sep 24;77(18):3671-3690. Epub 2020 Apr 24.

Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 M. Asias Street-Bldg. 16, 11527, Athens, Greece.

View Article and Find Full Text PDF
September 2020

Converging Roads to Early Bladder Cancer.

Eur Urol 2020 08 17;78(2):127-130. Epub 2020 Mar 17.

Department of Urology, San Raffaele Hospital and Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

View Article and Find Full Text PDF
August 2020

Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.

Clin Genitourin Cancer 2020 06 5;18(3):e266-e276. Epub 2019 Dec 5.

Division of Medical Oncology, Department of Medicine, University of Washington, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address:

View Article and Find Full Text PDF
June 2020

Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.

Urol Oncol 2020 07 11;38(7):639.e1-639.e9. Epub 2020 Feb 11.

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Departments of Urology, Weill Cornell Medical College, New York, New York; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia. Electronic address:

View Article and Find Full Text PDF
July 2020

Capturing recurrence in urothelial carcinoma: "more than meets the eye".

Transl Androl Urol 2019 Dec;8(Suppl 5):S524-S527

Department of Medicine, Division of Oncology, University of Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article and Find Full Text PDF
December 2019

The utility of next generation sequencing in advanced urothelial carcinoma.

Eur Urol Focus 2020 01 8;6(1):41-44. Epub 2019 Nov 8.

Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center. Electronic address:

View Article and Find Full Text PDF
January 2020

The importance of not only living longer but also better in the setting of advanced urothelial cancer.

Ann Transl Med 2019 Sep;7(Suppl 6):S187

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

View Article and Find Full Text PDF
September 2019

Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?

BJU Int 2019 09;124(3):361-362

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article and Find Full Text PDF
September 2019

Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of Immunotherapy.

Curr Treat Options Oncol 2019 06 28;20(8):67. Epub 2019 Jun 28.

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

View Article and Find Full Text PDF
June 2019

Preexisting Autoimmune Disease: Implications for Immune Checkpoint Inhibitor Therapy in Solid Tumors.

J Natl Compr Canc Netw 2019 06;17(6):750-757

Department of Medicine, Division of Oncology, University of Washington, and.

View Article and Find Full Text PDF
June 2019

Conceptual Framework for Therapeutic Development Beyond Anti-PD-1/PD-L1 in Urothelial Cancer.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:284-300. Epub 2019 May 17.

4 Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article and Find Full Text PDF
January 2019

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.

Oncologist 2019 05 29;24(5):580-583. Epub 2019 Mar 29.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

View Article and Find Full Text PDF
May 2019

Delays in radical cystectomy for muscle-invasive bladder cancer.

Cancer 2019 06 6;125(12):2011-2017. Epub 2019 Mar 6.

Department of Urology, University of Washington, Seattle, Washington.

View Article and Find Full Text PDF
June 2019

The Cancer Immunogram: A Pledge for a Comprehensive Biomarker Approach for Personalized Immunotherapy in Urothelial Cancer.

Eur Urol 2019 03 15;75(3):445-447. Epub 2018 Dec 15.

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchison Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, USA. Electronic address:

View Article and Find Full Text PDF
March 2019

DNA Damage Response Gene Alterations in Urothelial Cancer: Ready for Practice?

Authors:
Petros Grivas

Clin Cancer Res 2019 02 19;25(3):907-909. Epub 2018 Nov 19.

Genitourinary Cancers Program, Division of Oncology, Department of Medicine University of Washington, Seattle, Washington.

View Article and Find Full Text PDF
February 2019

Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.

Clin Genitourin Cancer 2018 12 22;16(6):e1237-e1242. Epub 2018 Aug 22.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA (current). Electronic address:

View Article and Find Full Text PDF
December 2018

Evaluation of T cell infiltration in matched biopsy and nephrectomy samples in renal cell carcinoma.

Medicine (Baltimore) 2018 Sep;97(37):e12344

Taussig Cancer Institute Department of Immunology, Lerner Research Institute Robert J. Tomsich Pathology and Laboratory Medicine Institute Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH University of Washington, Seattle, WA.

View Article and Find Full Text PDF
September 2018

Emerging biomarkers and targeted therapies in urothelial carcinoma.

Ann Transl Med 2018 Jun;6(12):250

Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA.

View Article and Find Full Text PDF
June 2018

Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.

Oncologist 2018 12 1;23(12):1494-1499. Epub 2018 Aug 1.

Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

View Article and Find Full Text PDF
December 2018

Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research.

Transl Androl Urol 2018 Jun;7(3):504-507

Department of Medicine, Division of Oncology, Genitourinary Cancers Program, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA.

View Article and Find Full Text PDF
June 2018

Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.

Eur Urol 2018 12 20;74(6):741-753. Epub 2018 Jul 20.

Michigan Center for Translational Pathology, Michigan Medicine, Ann Arbor, MI, USA; Department of Pathology, Michigan Medicine, Ann Arbor, MI, USA; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA; Department of Urology, Michigan Medicine, Ann Arbor, MI, USA. Electronic address:

View Article and Find Full Text PDF
December 2018

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook.

Ther Clin Risk Manag 2018 5;14:1019-1040. Epub 2018 Jun 5.

Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.

View Article and Find Full Text PDF
June 2018

mutations predict shorter overall survival in urothelial cancer.

Oncotarget 2018 Mar 30;9(24):16891-16898. Epub 2018 Mar 30.

Department of Medicine, Division of Hematology-Oncology, Penn State Cancer Institute, Hershey, PA, USA.

View Article and Find Full Text PDF
March 2018

Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma.

Curr Oncol Rep 2018 04 11;20(6):48. Epub 2018 Apr 11.

Department of Medicine, Division of Oncology, Seattle Cancer Care Alliance, University of Washington and Fred Hutchinson Cancer Research Center, 825 Eastlake Ave E, MS: G4-830, Seattle, WA, 98109, USA.

View Article and Find Full Text PDF
April 2018

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma.

J Immunother Cancer 2018 01 29;6(1). Epub 2018 Jan 29.

Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Desk CA60, Cleveland, OH, 44195, USA.

View Article and Find Full Text PDF
January 2018

Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer.

Clin Genitourin Cancer 2018 04 17;16(2):e437-e442. Epub 2017 Oct 17.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. Electronic address:

View Article and Find Full Text PDF
April 2018

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.

Urol Oncol 2018 09 8;36(9):413-422. Epub 2017 Nov 8.

Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address:

View Article and Find Full Text PDF
September 2018

Circulating Tumor DNA in Bladder Cancer: Novel Applications and Future Directions.

Eur Urol 2018 04 31;73(4):541-542. Epub 2017 Oct 31.

Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address:

View Article and Find Full Text PDF
April 2018

Immunobiology and immunotherapy in genitourinary malignancies.

Ann Transl Med 2016 Jul;4(14):270

Department of Hematology/Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, OH, USA.

View Article and Find Full Text PDF
July 2016